TABLE 1.
Biological Cluster | Endocannabinoid Signaling | Lipid Transport | Lipogenesis | Energy Expenditure | Energy Intake | Glucose Metabolism |
---|---|---|---|---|---|---|
Genes | Adipose tissues CB1, upper intestine CB1 and GPR119, upper intestine and adipose tissues FAAH and NAAA, upper intestine OEAs | Adipose tissues, liver and upper intestine CD36, liver PCSK9, upper intestine and adipose tissues FIAF | Liver FAS, SREBP1c, SREBP2, liver and adipose tissues SCD1, adipose tissue SREBP1c, and SREBP2 | Liver ACO, adipose tissue epid. Adiponectin, liver, upper intestine and adipose tissues CPT1, muscle UCP2, upper intestine PPAR-α | Upper intestine CCK, stomach leptin and ghrelin, adipose tissues leptin | Muscle GLUT4, liver G6P and PEPCK, adipose tissues visfatin |
Metabolites | Plasma cholesterol, plasma FFA, HDL-C, non-HDL-C, plasma TG | Liver TG, liver FA and glycerol | Plasma β-hydroxybutyrate | Plasma glucose | ||
Physiological parameters | FAAH activity in intestine | Plasma insulin | Adiponectin, indirect calorimetry LOX, GOX, RQ, and EE, spontaneous activity | Plasma ghrelin, plasma leptin, cumulative food intake | Plasma insulin |
RQ, respiratory quotient; TG, triglyceride. Biological variables in boldface type indicate those variables modified by treatments (with 95% confidence interval, as determined from the PLS analysis) and used to calculate the biological module scores (hierarchical PLS).